Literature DB >> 15215645

Phospholipase C involvement in activation of the muscarinic receptor-operated cationic current in Guinea pig ileal smooth muscle cells.

Hiroyuki Okamoto1, Toshihiro Unno, Daisuke Arima, Maki Suzuki, Hai-Dun Yan, Hayato Matsuyama, Masakazu Nishimura, Seiichi Komori.   

Abstract

In guinea pig single ileal smooth muscle cells held under voltage-clamp, the role of phospholipase C (PLC) in activation of the muscarinic receptor-operated cationic current (I(cat)) was studied. U73122, a PLC inhibitor, prevented the generation of I(cat) by the muscarinic agonist carbachol. The effect did not involve muscarinic receptor block since it also blocked I(cat) which was evoked by GTPgammaS applied intracellularly to activate G proteins bypassing muscarinic receptors. Also, neither cationic channel block nor other possible nonspecific actions seemed to be involved since its analogue (U73343), structurally close but deficient of the PLC-inhibiting activity, did not significantly affect carbachol- or GTPgammaS-evoked I(cat). Antibodies against the alpha subunits of G(q)/G(11) proteins (Galpha(q)/Galpha(11)-antibody) blocked only the small component of carbachol-evoked I(cat), which was associated with an increase in [Ca(2+)](i) linked to an increase in G(q/11) protein-regulated PLC activity. 1-Oleoyl-2-acetyl-sn-glycerol (OAG), an analogue of diacylglycerol (DAG) produced via PLC-catalyzed metabolism, produced no or only a small current by itself, with the carbachol-evoked I(cat) remaining unchanged. These results provide evidence for the importance of PLC in I(cat) generation, and they also strongly suggest that the activity of PLC involved in the primary activation of I(cat) is neither under regulation by G(q/11) proteins nor dependent on the action of DAG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215645     DOI: 10.1254/jphs.fp0030635

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  7 in total

1.  Phospholipase C-independent effects of 3M3FBS in murine colon.

Authors:  Laura Dwyer; Hyun Jin Kim; Byoung Ho Koh; Sang Don Koh
Journal:  Eur J Pharmacol       Date:  2009-11-18       Impact factor: 4.432

2.  Isoform-specific inhibition of TRPC4 channel by phosphatidylinositol 4,5-bisphosphate.

Authors:  Ken-ichi Otsuguro; Jisen Tang; Yufang Tang; Rui Xiao; Marc Freichel; Volodymyr Tsvilovskyy; Shigeo Ito; Veit Flockerzi; Michael X Zhu; Alexander V Zholos
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

3.  Three distinct muscarinic signalling pathways for cationic channel activation in mouse gut smooth muscle cells.

Authors:  Takashi Sakamoto; Toshihiro Unno; Takio Kitazawa; Tetsuro Taneike; Masahisa Yamada; Jürgen Wess; Masakazu Nishimura; Seiichi Komori
Journal:  J Physiol       Date:  2007-04-26       Impact factor: 5.182

4.  Deletion of TRPC4 and TRPC6 in mice impairs smooth muscle contraction and intestinal motility in vivo.

Authors:  Volodymyr V Tsvilovskyy; Alexander V Zholos; Thomas Aberle; Stephan E Philipp; Alexander Dietrich; Michael X Zhu; Lutz Birnbaumer; Marc Freichel; Veit Flockerzi
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

5.  Sub-plasmalemmal [Ca2+]i upstroke in myocytes of the guinea-pig small intestine evoked by muscarinic stimulation: IP3R-mediated Ca2+ release induced by voltage-gated Ca2+ entry.

Authors:  D V Gordienko; M I Harhun; M V Kustov; V Pucovský; T B Bolton
Journal:  Cell Calcium       Date:  2007-06-13       Impact factor: 6.817

Review 6.  Ionic Conductance(s) in Response to Post-junctional Potentials.

Authors:  Sang Don Koh; Poong-Lyul Rhee
Journal:  J Neurogastroenterol Motil       Date:  2013-10-07       Impact factor: 4.924

7.  TMEM16A knockdown abrogates two different Ca(2+)-activated Cl (-) currents and contractility of smooth muscle in rat mesenteric small arteries.

Authors:  Vibeke Secher Dam; Donna M B Boedtkjer; Jakob Nyvad; Christian Aalkjaer; Vladimir Matchkov
Journal:  Pflugers Arch       Date:  2013-10-27       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.